title: Inflammatory bowel diseases: principles of nutritional therapy.
abstract: Inflammatory Bowel Diseases - ulcerative colitis and Crohn's disease- are chronic gastrointestinal inflammatory diseases of unknown etiology. Decreased oral intake, malabsorption, accelerated nutrient losses, increased requirements, and drug-nutrient interactions cause nutritional and functional deficiencies that require proper correction by nutritional therapy. The goals of the different forms of nutritional therapy are to correct nutritional disturbances and to modulate inflammatory response, thus influencing disease activity. Total parenteral nutrition has been used to correct and to prevent nutritional disturbances and to promote bowel rest during active disease, mainly in cases of digestive fistulae with high output. Its use should be reserved for patients who cannot tolerate enteral nutrition. Enteral nutrition is effective in inducing clinical remission in adults and promoting growth in children. Due to its low complication rate and lower costs, enteral nutrition should be preferred over total parenteral nutrition whenever possible. Both present equal effectiveness in primary therapy for remission of active Crohn's disease. Nutritional intervention may improve outcome in certain individuals; however, because of the costs and complications of such therapy, careful selection is warranted, especially in patients presumed to need total parenteral nutrition. Recent research has focused on the use of nutrients as primary treatment agents. Immunonutrition is an important therapeutic alternative in the management of inflammatory bowel diseases, modulating the inflammation and changing the eicosanoid synthesis profile. However, beneficial reported effects have yet to be translated into the clinical practice. The real efficacy of these and other nutrients (glutamine, short-chain fatty acids, antioxidants) still need further evaluation through prospective and randomized trials.
authors.affiliation: Department of Gastroenterology, Coloproctology Unit, Hospital das Clínicas, Faculty of Medicine, University of São Paulo, Brazil.
authors.forename: Fábio Guilherme
authors.initials: FG
authors.lastname: Campos
authors.forename: Dan L
authors.initials: DL
authors.lastname: Waitzberg
authors.forename: Magaly Gemio
authors.initials: MG
authors.lastname: Teixeira
authors.forename: Donato Roberto
authors.initials: DR
authors.lastname: Mucerino
authors.forename: Angelita
authors.initials: A
authors.lastname: Habr-Gama
authors.forename: Desidério R
authors.initials: DR
authors.lastname: Kiss
mesh_terms: D003093:Colitis, Ulcerative / Q000150:complications / Q000178:diet therapy; D003424:Crohn Disease / Q000150:complications / Q000178:diet therapy; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000178:diet therapy*; D009748:Nutrition Disorders / Q000178:diet therapy* / Q000209:etiology / Q000517:prevention & control; D018529:Nutritional Support / Q000379:methods*